US Stock MarketDetailed Quotes

ITRM Iterum Therapeutics

Watchlist
  • 1.5900
  • -0.0100-0.63%
Trading May 9 12:04 ET
26.32MMarket Cap-537P/E (TTM)

About Iterum Therapeutics Company

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.

Company Profile

SymbolITRM
Company NameIterum Therapeutics
Listing DateMay 25, 2018
Issue Price13.00
Founded2015
CEOMr. Corey N. Fishman
MarketNASDAQ
Employees14
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressFitzwilliam Court,Leeson Close,1st Floor
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-669-4820
Websitehttp://www.iterumtx.com

Company Executives

  • Name
  • Position
  • Salary
  • Corey N. Fishman
  • Director, President and Chief Executive Officer
  • 1.52M
  • Judith M. Matthews
  • Chief Financial Officer and Principal Accounting Officer
  • 827.77K
  • Dr. Sailaja Puttagunta, M.D.
  • Chief Medical Officer
  • 1.01M
  • Dr. Michael W. Dunne
  • Director
  • 115.00K
  • Beth P. Hecht
  • Independent Director
  • 68.50K
  • Ronald M. Hunt, M.B.A.
  • Independent Director
  • 88.75K
  • David G Kelly
  • Independent Director
  • 74.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg